# Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial

> **NCT07293078** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **MetroWest Artificial Intelligence Research Workgroup** · enrollment: 1000 (estimated)

## Conditions studied

- Critical Illness
- Sepsis
- Acute Respiratory Failure (ARF)
- Multi-organ Failure
- Acute Kidney Injury
- Delirium Confusional State
- Shock

## Interventions

- **OTHER:** Point-of-care large language model decision support (ChatGPT-5)

## Key facts

- **NCT ID:** NCT07293078
- **Lead sponsor:** MetroWest Artificial Intelligence Research Workgroup
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-06-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07293078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07293078, "Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07293078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*